E-Mail
The unpopular guests are already here. Hazel-, alder- and elm tree pollen sweep in over us during the early spring months, with birch pollen following in May. Then grass follows in June-July before mugwort pollen closes the season in late summer. All leading to more and more people suffering.
Over fifty years, the proportion of young Danes who sneeze, rub itchy eyes or suffer a blocked nose because of pollen has grown from 7-8 per cent in the 1970s to 24 per cent today. And for asthma, the proportion has risen from 4 to 12 per cent during the same period. This is shown by a study of 53,000 Danish blood donors published by researchers from Aarhus University in collaboration with the Blood Bank at Aarhus University Hospital.
Hay fever and asthma affect more people, and earlier – TodayHeadline todayheadline.co - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from todayheadline.co Daily Mail and Mail on Sunday newspapers.
Kimchi is a traditional side dish in S. Korea, and this is present in every meal. It is a fermented cabbage dish that is a staple in Korean cuisine, and a new study shows it may also help with easing COVID-19 symptoms.
As per The Korea Herald, this claim resulted from a recent study that was jointly worked on by the World Institute of Kimchi and Jean Bousquet, an honorary professor at France’s Montpellier University’s Pulmonary Medicine, while the WIK is a government-funded organization.
The findings in the research
The study revealed that eating kimchi may help lessen the effect of coronavirus and make it a mild case. It was said that this is because of the bioactive compounds found in the side dish.
BetterLife Pharma Inc says subsidary Altum Pharmaceuticals has entered into a Letter of Intent with Pontificia Universidad Católica de Chile to conduct a coronavirus trial testing Altum s inhaled interferon alpha-2b product AP-003 proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.
Open access journal Clinical and Translational Allergy (CTA) published by Wiley as of January 2021
The European Academy of Allergy and Clinical Immunology (EAACI) and John Wiley & Sons Inc., a global leader in research and education, have expanded their publishing partnership to include EAACI’s official open access journal Clinical and Translational Allergy (CTA) alongside their other publications, Allergy and Pediatric Allergy and Clinical Immunology, as of January 2021.
CTA is a fully open access journal, edited by Prof. Jean Bousquet and Dr. Clive Grattan, and provides a dissemination of allergy research and reviews, as well as EAACI position papers, task force reports, and guidelines for an international scientific audience.